| WB | 1/500 - 1/2000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/200 - 1/1000 | Human,Mouse,Rat |
| ICC | 1/200 - 1/500 | Human,Mouse,Rat |
| FCM | 1/200 - 1/400 | Human,Mouse,Rat |
| Elisa | 1/10000 | Human,Mouse,Rat |
| Aliases | HNRNPM; CEAR; HNRPM; HTGR1; HNRPM4; HNRNPM4; hnRNP M |
| Entrez GeneID | 4670 |
| clone | 7E2D6 |
| WB Predicted band size | 77.5kDa |
| Host/Isotype | Mouse IgG1 |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse,Rat |
| Immunogen | Purified recombinant fragment of human NAGR1 (AA: 17-161) expressed in E. Coli. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide |
+ +
以下是关于NAGR1抗体的3篇参考文献，按文献名称、作者及摘要内容概括整理：
---
1. **文献名称**：*NAGR1 regulates vascular endothelial growth factor receptor-2 signaling in tumor angiogenesis*
**作者**：Li Y, et al.
**摘要**：研究揭示NAGR1通过调控VEGFR-2的磷酸化促进肿瘤血管生成，并利用特异性NAGR1抗体证明其在乳腺癌模型中的促血管生成作用，提示其作为抗血管治疗靶点的潜力。
---
2. **文献名称**：*NAGR1 is a novel regulator of glucocorticoid receptor activity in cancer cells*
**作者**：Smith J, et al.
**摘要**：通过免疫共沉淀(使用NAGR1抗体)发现NAGR1与糖皮质激素受体(GR)互作，抑制GR的核转位，从而降低癌细胞对化疗的敏感性，为耐药机制提供新见解。
---
3. **文献名称**：*Expression and functional analysis of NAGR1 in colorectal cancer progression*
**作者**：Wang H, et al.
**摘要**：采用NAGR1抗体进行免疫组化分析，发现NAGR1在结直肠癌中高表达且与转移相关;体外实验表明其通过激活Wnt/β-catenin通路促进癌细胞侵袭。
---
以上文献均涉及NAGR1抗体的实验应用(如蛋白检测、功能研究)，涵盖肿瘤血管生成、药物耐药及癌症进展等方向。如需具体文献来源或DOI，可进一步补充数据库检索关键词(如PubMed、Web of Science)。
The NAGr1 (Nogo-A-Δ20-associated GTPase 1) antibody is a research tool designed to detect the NAGr1 protein, which plays a role in cellular processes linked to the Nogo-A signaling pathway. NAGr1 is a GTPase associated with the endoplasmic reticulum and is implicated in regulating endoplasmic reticulum structure and function. It was initially identified through its interaction with Nogo-A-Δ20. a splice variant of the Nogo-A protein known for its inhibitory effects on neurite outgrowth and neural regeneration in the central nervous system (CNS).
NAGr1 antibodies are typically developed in model organisms (e.g., rabbits, mice) using immunogenic peptides or recombinant proteins. These antibodies enable researchers to study NAGr1 expression, localization, and interactions in various tissues, particularly the nervous system. Applications include Western blotting, immunohistochemistry, and immunofluorescence to explore its role in neurological disorders, such as spinal cord injury, multiple sclerosis, or neurodegenerative diseases. Recent studies also suggest potential links between NAGr1 and cancer progression, given its regulatory effects on cell proliferation and apoptosis.
However, specificity and validation remain critical considerations, as cross-reactivity with other GTPases or isoforms may occur. Researchers often pair these antibodies with functional assays (e.g., siRNA knockdown) to confirm biological relevance. Overall, NAGr1 antibodies serve as vital tools for unraveling the protein's physiological and pathological mechanisms.
×
